ArticleCancer science2026

Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

Takahiro Kumode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.